Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=40203031&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP056216(A)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biovail Lab Int SrlfiledCriticalBiovail Lab Int Srl
Priority to ECSP056216priorityCriticalpatent/ECSP056216A/en
Publication of ECSP056216ApublicationCriticalpatent/ECSP056216A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Una tableta de liberación modificada de clorhidrato de bupropion, que comprende (i) un núcleo que comprende una cantidad efectiva de clorhidrato de bupropion, un aglutinante, un lubricante y (ii) un recubrimiento para controlar la liberación que rodea el núcleo y (iii) una barrera contra la humedad que rodea el recubrimiento para controlar la liberación, en done la tableta de liberación modificada es bioequivalente a las tabletas de Wellbutrin® o de Zyban®/Wellbutrin®SR.A modified release tablet of bupropion hydrochloride, comprising (i) a core comprising an effective amount of bupropion hydrochloride, a binder, a lubricant and (ii) a coating to control the release surrounding the core and (iii) a moisture barrier surrounding the coating to control release, where the modified-release tablet is bioequivalent to Wellbutrin® or Zyban® / Wellbutrin®SR tablets.
COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
USE OF A COPOLIMERO OF (MET) ANIONIC ACRYLATE, PARTLY NEUTRALIZED, AS A COVER FOR THE PRODUCTION OF A PHARMACEUTICAL FORM THAT RELEASES ACTIVE SUBSTANCE WITH REDUCED PH VALUES.
COMPOUNDS DERIVED FROM DIHIDRO AND TETRAHIDRO OXAZOLOPIRIMIDINONAS REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF CHICHOPHRENIA, EPILEPSY, BETWEEN OTHER DISEASES.
COMPOUNDS DERIVED FROM PYRIDOPIRIMIDINONES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PAIN, DEPRESSION, CARDIOVASCULAR DISEASES, RESPIRATORY DISEASES AND PSYCHIATRIC DISEASES.
Pharmaceutical composition comprising 100 to 2000 mg of metformin and 10 to 300 mg of a glucopyranosyl substituted phenyl derivative sglt-2 inhibitor compound, microcrystalline cellulose, a binder and croscarmellose.
COMPOSITION THAT INCLUDES AT LEAST AN IRONING COMBINING COMPOUND AND AT LEAST AN ANTIFUNGIC AGENT; AND METHOD FOR THE TREATMENT OR PREVENTION OF A FUNGICAL CONDITION.
METHOD FOR THE TREATMENT OF OCULAR HYPERTENSION THAT INCLUDES A SMALL MOLECULA AGENT THAT INTERACTS WITH A CODIFYING GENE FOR SERICA AMYLOID PROTEIN A (SAA).
Compounds derived from heterocycles; its preparation process; fungicidal composition comprising said compounds; and method to combat or control phytopathogenic fungi.
Compounds derived from alkylheterocycles carbamates; preparation procedure; pharmaceutical composition; and its use to prevent or treat acute or chronic pain, neurological and psychiatric pathologies, cardiovascular diseases, among others.